Neuronetics ROA 2018-2018 | STIM
Current and historical return on assets (ROA) values for Neuronetics (STIM) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Neuronetics ROA for the three months ending June 30, 2018 was 0.00%.
| Neuronetics Annual ROA | |
|---|---|
| 2017 | -41.24 |
| 2016 | -45.30 |
| Neuronetics Quarterly ROA | |
|---|---|
| Q2 2018 | -26.45 |
| Q4 2017 | 0.00 |
| Q2 2017 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.603B | $0.040B |
| Neuronetics, Inc. is a commercial-stage medical device company. It focused on designing, developing, and marketing products for patients who suffer from psychiatric disorders. NeuroStar Advanced Therapy System(R), is the transcranial magnetic stimulation treatment for depressive disorder. Neuronetics, Inc. is based in Malvern, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $98.077B | 23.53 |
| Intuitive Surgical (ISRG) | United States | $63.331B | 60.45 |
| Edwards Lifesciences (EW) | United States | $32.178B | 36.24 |
| Fresenius Medical Care (FMS) | Germany | $31.319B | 22.12 |
| IDEXX Laboratories (IDXX) | United States | $20.880B | 63.46 |
| ABIOMED (ABMD) | United States | $17.272B | 141.50 |
| Teleflex (TFX) | United States | $12.353B | 29.39 |
| DexCom (DXCM) | United States | $12.326B | 0.00 |
| Hologic (HOLX) | United States | $11.222B | 19.09 |
| Varian Medical Systems (VAR) | United States | $10.297B | 25.92 |
| STERIS (STE) | United Kingdom | $9.636B | 26.50 |
| Masimo (MASI) | United States | $6.344B | 42.24 |
| LivaNova (LIVN) | United Kingdom | $5.944B | 35.46 |
| Inogen (INGN) | United States | $5.438B | 143.90 |
| Integra LifeSciences Holdings (IART) | United States | $5.381B | 27.85 |
| Globus Medical (GMED) | United States | $5.316B | 35.36 |
| Penumbra (PEN) | United States | $5.135B | 466.72 |
| Cantel Medical (CMD) | United States | $4.058B | 42.30 |
| Halyard Health (AVNS) | United States | $3.231B | 26.59 |
| Wright Medical Group (WMGI) | Netherlands | $2.988B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.683B | 24.29 |
| Opko Health (OPK) | United States | $2.418B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.320B | 0.00 |
| Glaukos (GKOS) | United States | $2.054B | 1176.80 |
| Nevro (NVRO) | United States | $1.784B | 0.00 |
| Mazor Robotics (MZOR) | Israel | $1.531B | 0.00 |
| AxoGen (AXGN) | United States | $1.374B | 0.00 |
| Luminex (LMNX) | United States | $1.309B | 38.62 |
| CryoLife (CRY) | United States | $1.272B | 111.61 |
| Accelerate Diagnostics (AXDX) | United States | $1.221B | 0.00 |
| K2Ms (KTWO) | United States | $1.190B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.172B | 199.72 |
| Natus Medical (BABY) | United States | $1.152B | 24.43 |
| Orthofix (OFIX) | United States | $1.017B | 30.97 |
| Intersect ENT (XENT) | United States | $0.901B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.872B | 32.21 |
| ViewRay (VRAY) | United States | $0.733B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.698B | 43.16 |
| Sientra (SIEN) | United States | $0.692B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.635B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.438B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.418B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.415B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.360B | 0.00 |
| IRadimed (IRMD) | United States | $0.357B | 128.65 |
| Accuray (ARAY) | United States | $0.355B | 0.00 |
| Veracyte (VCYT) | United States | $0.346B | 0.00 |
| Nuvectra (NVTR) | United States | $0.320B | 0.00 |
| Fluidigm (FLDM) | United States | $0.308B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.282B | 55.63 |
| T2 Biosystems (TTOO) | United States | $0.277B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.234B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.234B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.228B | 0.00 |
| Invuity (IVTY) | United States | $0.178B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.151B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.138B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.138B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.125B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.124B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.120B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.094B | 0.00 |
| EDAP TMS (EDAP) | France | $0.083B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.077B | 0.00 |
| ConforMIS (CFMS) | United States | $0.075B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.061B | 0.00 |
| Neovasc (NVCN) | Canada | $0.057B | 0.00 |
| Vermillion (VRML) | United States | $0.053B | 0.00 |
| PAVmed (PAVM) | United States | $0.035B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.032B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.032B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.031B | 0.00 |
| Presbia (LENS) | Ireland | $0.030B | 0.00 |
| Dynatronics (DYNT) | United States | $0.023B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.020B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.020B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.017B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.017B | 0.00 |
| Avinger (AVGR) | United States | $0.016B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.013B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.009B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.008B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.008B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.008B | 0.00 |
| Amedica (AMDA) | United States | $0.003B | 0.00 |
| EnteroMedics (RSLS) | United States | $0.000B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
